Literature DB >> 25443037

HIV testing and counselling in Estonian prisons, 2012 to 2013: aims, processes and impacts.

K Kivimets1, A Uuskula.   

Abstract

We present data from an observational cohort study on human immunodeficiency virus (HIV) prevention and control measures in prisons in Estonia to assess the potential for HIV transmission in this setting. HIV testing and retesting data from the Estonian prison health department were used to estimate HIV prevalence and incidence in prison. Since 2002, voluntary HIV counselling and testing has routinely been offered to all prisoners and has been part of the new prisoners health check. At the end of 2012, there were 3,289 prisoners in Estonia, including 170 women: 28.5% were drug users and 15.6% were infected with HIV. Of the HIV-positive inmates, 8.3% were newly diagnosed on prison entry. In 2012, 4,387 HIV tests (including retests) were performed in Estonian prisons. Among 1,756 initially HIV-negative prisoners who were in prison for more than one year and therefore tested for HIV twice within 12 months (at entry and annual testing), one new HIV infection was detected, an incidence of 0.067 per 100 person-years (95% confidence interval (CI): 0.025–5.572). This analysis indicates low risk of HIV transmission in Estonian prisons. Implementation of HIV management interventions could impact positively on the health of prisoners and the communities to which they return.

Entities:  

Mesh:

Year:  2014        PMID: 25443037     DOI: 10.2807/1560-7917.es2014.19.47.20970

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  5 in total

Review 1.  The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia.

Authors:  Frederick L Altice; Lyuba Azbel; Jack Stone; Ellen Brooks-Pollock; Pavlo Smyrnov; Sergii Dvoriak; Faye S Taxman; Nabila El-Bassel; Natasha K Martin; Robert Booth; Heino Stöver; Kate Dolan; Peter Vickerman
Journal:  Lancet       Date:  2016-07-14       Impact factor: 79.321

2.  Active Case Finding for Communicable Diseases in Prison Settings: Increasing Testing Coverage and Uptake Among the Prison Population in the European Union/European Economic Area.

Authors:  Lara Tavoschi; Hilde Vroling; Giordano Madeddu; Sergio Babudieri; Roberto Monarca; Marije Vonk Noordegraaf-Schouten; Netta Beer; Joana Gomes Dias; Éamonn O'Moore; Dagmar Hedrich; Anouk Oordt-Speets
Journal:  Epidemiol Rev       Date:  2018-06-01       Impact factor: 6.222

3.  Missed opportunities for HIV testing in people diagnosed with HIV, Estonia, 2014 to 2015.

Authors:  Kristi Rüütel; Liis Lemsalu; Sirly Lätt; Jevgenia Epštein
Journal:  Euro Surveill       Date:  2019-04

4.  HIV seroprevalence in five key populations in Europe: a systematic literature review, 2009 to 2019.

Authors:  Annemarie Rinder Stengaard; Lauren Combs; Virginie Supervie; Sara Croxford; Sarika Desai; Ann K Sullivan; Stine Finne Jakobsen; Quenia Santos; Daniel Simões; Jordi Casabona; Jeffrey V Lazarus; John B F de Wit; Frank M Amort; Anastasia Pharris; Lina Nerlander; Dorthe Raben
Journal:  Euro Surveill       Date:  2021-11

5.  Hepatitis C seropositivity among newly incarcerated prisoners in Estonia: data analysis of electronic health records from 2014 to 2015.

Authors:  Kristel Kivimets; Anneli Uusküla; Jeffrey V Lazarus; Kristi Ott
Journal:  BMC Infect Dis       Date:  2018-07-21       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.